These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 11802055)

  • 21. Induction of mucin gene expression in middle ear of rats by tumor necrosis factor-alpha: potential cause for mucoid otitis media.
    Lin J; Haruta A; Kawano H; Ho SB; Adams GL; Juhn SK; Kim Y
    J Infect Dis; 2000 Sep; 182(3):882-7. PubMed ID: 10950784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysozyme levels in middle ear effusion and serum in otitis media.
    Harada T; Juhn SK; Adams GL
    Arch Otolaryngol Head Neck Surg; 1990 Jan; 116(1):54-6. PubMed ID: 2294941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronic acid in secretory otitis media. A biochemical study of mucoid middle-ear effusions and serum.
    Laurent C; Tengblad A; Engström-Laurent A
    J Laryngol Otol; 1986 Feb; 100(2):135-40. PubMed ID: 3950472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MUC5AC expression in human middle ear epithelium of patients with otitis media.
    Kerschner JE; Tripathi S; Khampang P; Papsin BC
    Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):819-24. PubMed ID: 20713760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions.
    Furukawa M; Kubo N; Yamashita T
    Laryngoscope; 1995 Feb; 105(2):188-91. PubMed ID: 8544602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Chlamydia trachomatis with polymerase chain reaction in middle ear fluid in otitis media with effusion.
    Keles E; Bulut Y; Kaygusuz I; Karlidag T; Yalçin S; Ozdarendeli A; Alpay HC
    Indian Pediatr; 2005 Jul; 42(7):686-91. PubMed ID: 16085970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The levels of IL-1 beta in human middle ear effusions.
    Juhn SK; Tolan CT; Garvis WJ; Cross DS; Giebink GS
    Acta Otolaryngol Suppl; 1992; 493():37-42. PubMed ID: 1636421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mastocytes in chronic inflammation of middle ear mucosa].
    Sanković S; Dergenc R; Bojić P
    Srp Arh Celok Lek; 1999; 127(1-2):35-8. PubMed ID: 10377839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PO2 levels in middle ear effusions and middle ear mucosa.
    Takahashi M; Niwa H; Yanagita N
    Acta Otolaryngol Suppl; 1990; 471():39-42. PubMed ID: 2239244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The expression of RANTES interleukin 1beta and endotoxin in the effusion of secretory otitis media].
    Liang G; Cui Y; Wei M; Liu Z; Wang C
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):411-3. PubMed ID: 15499983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis and pathophysiology of middle ear effusions.
    Hörmann K
    Acta Otolaryngol Suppl; 1987; 440():1-59. PubMed ID: 3480679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Otitis media and chronic middle ear effusion in the asthmatic pediatric patient.
    Gamble JE; Bizal JA; Daetwyler EP
    Ear Nose Throat J; 1992 Sep; 71(9):397-9. PubMed ID: 1425378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Gel-Forming Mucins and Aquaporin Gene Expression With Hearing Loss, Effusion Viscosity, and Inflammation in Otitis Media With Effusion.
    Samuels TL; Yan JC; Khampang P; Dettmar PW; MacKinnon A; Hong W; Johnston N; Papsin BC; Chun RH; McCormick ME; Kerschner JE
    JAMA Otolaryngol Head Neck Surg; 2017 Aug; 143(8):810-817. PubMed ID: 28594978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell adhesion molecules and cytokines in middle ear effusions in children with or without recent acute otitis media.
    Russo E; Smith CW; Friedman EM; Smith EO; Kaplan SL
    Otolaryngol Head Neck Surg; 2004 Feb; 130(2):242-8. PubMed ID: 14990922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of mucin and adhesion molecules in middle ear mucosa.
    Schousboe LP; Rasmussen LM; Ovesen T
    Acta Otolaryngol; 2001 Jul; 121(5):596-601. PubMed ID: 11583392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of otitis media with effusion based on the ratio of albumin and immunoglobulin G concentrations in the effusion.
    Rezes S; Késmárki K; Sipka S; Sziklai I
    Otol Neurotol; 2007 Aug; 28(5):663-7. PubMed ID: 17667774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytologic characteristics of chronic secretory otitis].
    Adzić M; Andrić V; Djordjević I
    Srp Arh Celok Lek; 2002; 130 Suppl 1():22-4. PubMed ID: 12395458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of mucus glycoproteins in secretory otitis media.
    Brown DT; Litt M; Potsic WP
    Arch Otolaryngol; 1985 Oct; 111(10):688-95. PubMed ID: 4041172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretory lysozyme of the human middle ear mucosa: immunocytochemical localization.
    Lim DJ; Liu YS; Birck H
    Ann Otol Rhinol Laryngol; 1976; 85(1 Pt 1):50-60. PubMed ID: 944008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TH1/TH2 and regulatory cytokines in adults with otitis media with effusion.
    Kariya S; Okano M; Hattori H; Sugata Y; Matsumoto R; Fukushima K; Schachern PA; Cureoglu S; Paparella MM; Nishizaki K
    Otol Neurotol; 2006 Dec; 27(8):1089-93. PubMed ID: 16988618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.